Physician profile
Mark E Whitten
NPI 1306928965
$3,996.98
in general payments reported to CMS, 2019-2025
15 companies · $290 in 2025
The $290 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $54.07 · 2021: $347 · 2022: $2,221 · 2023: $97.83 · 2024: $749 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,137.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,771.87 | 2019-2025 | Clareon, Clareon Panoptix Pro, Hydrus Microstent |
| Johnson & Johnson Surgical Vision, INC. | $329.52 | 2021-2025 | Tecnis Iol, Tecnis Simplicity, Veritas Vision System |
| Allergan, INC. | $161.40 | 2019-2021 | |
| Rxsight INC | $108.49 | 2021-2024 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Carl Zeiss Meditec USA, INC. | $105.95 | 2025 | Cirrus Hd-Oct |
| Tarsus Pharmaceuticals, INC. | $103.74 | 2024-2025 | Xdemvy |
| New World Medical,INC. | $96.95 | 2022 | |
| Staar Surgical Company | $78.56 | 2019 | |
| Sun Pharmaceutical Industries INC. | $75.55 | 2022-2024 | |
| Bausch & Lomb Americas INC. | $36.16 | 2022-2025 | Miebo |
| Omeros Corporation | $31.11 | 2019-2021 | |
| Oyster Point Pharma, INC. | $28.50 | 2022 | |
| Kala Pharmaceuticals, INC. | $23.88 | 2021 | |
| Abbvie INC. | $23.27 | 2025 | |
| Mallinckrodt Hospital Products INC. | $22.03 | 2024 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Whitten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.